Skip to main content
. 2014 Feb;64(1):44–49.

Table 3.

Response of follicular hormones and ovarian follicle growth to ovarian stimulation in control (n= 5) and obese (n= 4) Ossabaw pigs

Stage of superovulation protocol
Initial 1st third 2nd third Last third 1 d after hCG 2 d after hCG
Testosterone (ng/mL) Control 0.6 ± 0.3 0.6 ± 0.3 1.0 ± 0.3 1.3 ± 0.3 1.2 ± 0.3 1.5 ± 0.3
Obese 0.6 ± 0.4 0.7 ± 0.4 1.6 ± 0.4 1.7 ± 0.4 1.5 ± 0.4 1.5 ± 0.3
Androstenedione (ng/mL) Control 0.8 ± 1.8 1.1 ± 1.5 2.4 ± 1.5 3.2 ± 1.5 2.7 ± 1.5 2.5 ± 1.5
Obese 0.8 ± 2.0 1.3 ± 2.0 4.8 ± 2.0 8.5 ± 2.0 6.0 ± 2.0 3.9 ± 2.0
Estradiol (pg/mL) Control 10.6 ± 68.1 24.1 ± 56.3 68.6 ± 56.3 69.3 ± 56.3 67.0 ± 56.3 59.3 ± 60.0
Obese 13.3 ± 112.2 29.6 ± 72.7 151.4 ± 72.7 241.2 ± 72.7 66.6 ± 72.7 47.3 ± 72.7
Progesterone (ng/mL) Control 1.6 ± 0.5 1.4 ± 0.4 2.0 ± 0.6 4.1 ± 2.3 4.5 ± 3.0 10.8 ± 7.9
Obese 1.7 ± 0.5 1.3 ± 0.5 2.1 ± 0.7 4.1 ± 3.0 5.2 ± 3.8 21.6 ± 10.2
Ovulatory size follicles Control 1.5 ± 0.7 0.7 ± 1.0 7.1 ± 3.0 17.7 ± 11.6 21.1 ± 10.2 17.0 ± 7.4
Obese 0.5 ± 0.8 1.4 ± 1.2 15.4 ± 3.4 34.6 ± 13.4 39.8 ± 11.8 12.2 ± 8.5
Postovulatory size follicles Control 0.0 ± 1.5 0.0 ± 1.5 0.0 ± 1.5 1.6 ± 1.5 2.5 ± 1.5 3.4 ± 1.5a
Obese 0.0 ± 1.7 0.0 ± 1.7 0.0 ± 1.7 0.0 ± 1.7 5.1 ± 1.7 8.8 ± 1.7b

a,bValues are significantly (P = 0.04) different.

HHS Vulnerability Disclosure